Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evolus, Inc. - Common Stock
(NQ:
EOLS
)
7.350
-0.170 (-2.26%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolus, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Evolus to Participate in September Conferences
August 29, 2023
From
Evolus
Via
Business Wire
Evolus Announces Inducement Grants for New Chief Marketing Officer
August 23, 2023
From
Evolus
Via
Business Wire
Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer
August 21, 2023
From
Evolus
Via
Business Wire
Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying
↗
August 16, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Earnings Preview: Evolus
↗
August 01, 2023
Via
Benzinga
5 Analysts Have This to Say About Evolus
↗
July 28, 2023
Via
Benzinga
Evolus Inc. (NASDAQ: EOLS) Highlighted for Surprising Price Action
July 27, 2023
Via
Investor Brand Network
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers
August 08, 2023
From
Evolus
Via
Business Wire
Evolus Reports Second Quarter 2023 Results and Provides Business Update
August 02, 2023
From
Evolus
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 27, 2023
Via
Benzinga
Why Shares of Evolus Are Jumping Thursday
↗
July 27, 2023
The stock climbed on record second-quarter revenue and a raise in full-year guidance.
Via
The Motley Fool
Expert Ratings for Evolus
↗
May 26, 2023
Via
Benzinga
This Analyst Likes Evolus As 'Top Play In Aesthetics'
↗
May 10, 2023
Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S.
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
Comcast, STMicroelectronics, Lam Research, Meta Platforms And Other Big Stocks Moving Higher On Thursday
↗
July 27, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue
July 27, 2023
From
Evolus
Via
Business Wire
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
July 26, 2023
From
Evolus, Inc.
Via
Business Wire
Evolus to Report Second Quarter 2023 Results and Provide Business Update
July 19, 2023
From
Evolus
Via
Business Wire
Twitter Faces Threats From AI and Threads
↗
July 15, 2023
AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience.
Via
The Motley Fool
Expert Ratings for Evolus
↗
May 10, 2023
Via
Benzinga
Evolus: Q1 Earnings Insights
↗
May 09, 2023
Via
Benzinga
Evolus Earnings Preview
↗
May 08, 2023
Via
Benzinga
Analyst Expectations for Evolus's Future
↗
March 09, 2023
Via
Benzinga
Evolus Launches Nuceiva® (botulinum toxin type A) in Italy
June 29, 2023
From
Evolus
Via
Business Wire
Evolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ®
June 22, 2023
From
Evolus
Via
Business Wire
Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program
June 08, 2023
From
Evolus
Via
Business Wire
Evolus Reports First Quarter 2023 Results and Provides Business Update
May 09, 2023
From
Evolus
Via
Business Wire
Evolus Announces Expansion into U.S. Dermal Filler Market with Evolysse™, a First-Generation Cold Technology HA by Symatese
May 09, 2023
From
Evolus, Inc.
Via
Business Wire
Evolus to Report First Quarter 2023 Results and Provide Business Update
May 05, 2023
From
Evolus, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
